Key characteristics that distinguish Prime Peptides from every telehealth platform reviewed in this series: No licensed prescriber reviews patient eligibility before purchase No medical consultation, health screening, or intake questionnaire No diagnosis required No clinical oversight during use, no provider messaging, no follow-up, no dose adjustment support Products are not compounded under 503A or 503B pharmacy standards Products are not FDA-approved and have not been evaluated for safety, efficacy, or quality as finished medical products No cold-chain shipping requirements or temperature verification, lyophilized powder format avoids refrigeration concerns during transit, but requires careful reconstitution and storage after delivery Pricing and What Reviewers Say Semaglutide is listed at $75 per vial in a 3mL format, dramatically lower than any telehealth compounded GLP-1 program in this review series
2021, NEJM) for Wegovy or SURMOUNT-1 (Jastreboff et al
The company serves adults across all 50 states via telehealth consultation, offering Compounded Semaglutide Injection at $189/mo month-to-month, or from $149/mo on the 6-month plan without insurance requirements
Because of its glucagon activation, Retatrutide may help sustain metabolic rate even after significant weight loss potentially reducing the yo-yo effect often seen when metabolism slows with dieting alone
(PubMed) Patrick L
Not all patients respond identically to minimum doses